Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 231.06 USD 0.68% Market Closed
Market Cap: 19.3B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Laboratory Corporation of America Holdings
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Laboratory Corporation of America Holdings
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Laboratory Corporation of America Holdings
NYSE:LH
Cash from Financing Activities
$880.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cash from Financing Activities
-$655.1m
CAGR 3-Years
5%
CAGR 5-Years
31%
CAGR 10-Years
-13%
Quest Diagnostics Inc
NYSE:DGX
Cash from Financing Activities
$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
21%
CVS Health Corp
NYSE:CVS
Cash from Financing Activities
-$2.5B
CAGR 3-Years
40%
CAGR 5-Years
11%
CAGR 10-Years
1%
Cigna Corp
NYSE:CI
Cash from Financing Activities
-$5.6B
CAGR 3-Years
19%
CAGR 5-Years
-39%
CAGR 10-Years
-15%
R1 RCM Inc
NASDAQ:RCM
Cash from Financing Activities
$490.9m
CAGR 3-Years
159%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Laboratory Corporation of America Holdings
Glance View

Market Cap
19.3B USD
Industry
Health Care
Economic Moat
None

Laboratory Corporation of America Holdings, commonly known as LabCorp, stands as a formidable player in the world of healthcare diagnostics. Emerging from a confluence of scientific innovation and business acumen, LabCorp has carved a niche within the intricate fabric of healthcare services. Since its inception, the company has excelled in offering a comprehensive suite of laboratory-based tests and services, empowering physicians and healthcare providers with critical insights needed for effective patient diagnosis and management. With its headquarters in Burlington, North Carolina, LabCorp operates a vast network of laboratories and patient service centers across the nation, providing services that range from routine blood work to sophisticated genomic testing. The essence of LabCorp’s business model lies in seamless integration across the healthcare continuum, driving both operational efficiency and profitability. Fundamentally, the company generates revenue by performing diagnostic tests on patient specimens, serving hospitals, managed care organizations, physician offices, and governmental agencies. As healthcare systems evolve towards precision medicine, LabCorp has harnessed emerging technologies and innovations like genomic testing to enhance its service offerings. This expansion not only aligns with changing healthcare paradigms but also fortifies its market leadership. By continually investing in research and development, LabCorp keeps its services at the cutting edge, ensuring steady growth and resilience in an ever-changing healthcare landscape.

LH Intrinsic Value
254.71 USD
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Laboratory Corporation of America Holdings's Cash from Financing Activities?
Cash from Financing Activities
880.1m USD

Based on the financial report for Sep 30, 2024, Laboratory Corporation of America Holdings's Cash from Financing Activities amounts to 880.1m USD.

What is Laboratory Corporation of America Holdings's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
5 928%

Over the last year, the Cash from Financing Activities growth was 5 928%.

Back to Top